AC Immune SA Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.31 | -$0.02 | -$0.14 |
| Q2 2024 | 1 | $0.47 | $0.48 | $0.48 |
| Q3 2024 | 1 | -$0.31 | -$0.02 | -$0.14 |
| Q4 2024 | 3 | -$0.19 | -$0.16 | -$0.18 |
| Q1 2025 | 1 | $0.00 | $0.00 | $0.00 |
AC Immune SA Earnings Date And Information
AC Immune SA last posted its earnings results on Tuesday, November 5th, 2024. The company reported $0.06 earnings per share for the quarter, topping analysts' consensus estimates of $-0.22 by $0.28. The company had revenue of 25.49 M for the quarter and had revenue of 14.80 M for the year. AC Immune SA has generated $-1 earnings per share over the last year ($-0.64 diluted earnings per share) and currently has a price-to-earnings ratio of -6.94. AC Immune SA has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 13th, 2025 based on prior year's report dates.
AC Immune SA Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/05/2024 | Q3 2024 | -$0.22 | $0.06 | 0.28 | $7.20 M | $25.49 M |
| 05/13/2024 | Q2 2024 | -$0.15 | -$0.23 | -0.08 | $90.89 M | $687,000 |
| 05/13/2024 | Q1 2024 | -$0.15 | -$0.18 | -0.03 | $0 | |
| 03/14/2024 | Q4 2023 | -$0.07 | -$0.05 | 0.02 | $14.80 M | |
| 11/03/2023 | Q3 2023 | -$0.02 | -$0.18 | -0.16 | $50.07 M | $0 |
| 08/04/2023 | Q2 2023 | -$0.22 | -$0.20 | 0.02 | $2.50 M | $0 |
| 04/28/2023 | Q1 2023 | -$0.24 | -$0.21 | 0.03 | $0 | |
| 03/16/2023 | Q4 2022 | -$0.28 | -$0.22 | 0.06 | $1,000 | |
| 10/28/2022 | Q3 2022 | -$0.24 | -$0.16 | 0.08 | $349,150 | $3.93 M |
| 04/28/2022 | Q2 2022 | -$0.23 | -$0.23 | 0 | $0 | |
| 04/28/2022 | Q1 2022 | -$0.23 | -$0.23 | 0 | $0 | |
| 11/08/2021 | Q4 2021 | -$0.29 | -$0.29 | 0 | $0 | |
| 11/08/2021 | Q3 2021 | -$0.29 | -$0.22 | 0.07 | $631,681 | $0 |
| 04/28/2021 | Q2 2021 | -$0.21 | -$0.26 | -0.05 | $1.77 M | $0 |
| 04/28/2021 | Q1 2021 | -$0.21 | -$0.23 | -0.02 | $0 | |
| 11/13/2020 | Q4 2020 | -$0.24 | -$0.27 | -0.03 | $944,000 | |
| 08/05/2020 | Q3 2020 | -$0.28 | -$0.26 | 0.02 | $424,995 | $1.12 M |
| 05/04/2020 | Q2 2020 | -$0.17 | -$0.22 | -0.05 | $199,466 | $1.28 M |
| 05/04/2020 | Q1 2020 | -$0.17 | -$0.11 | 0.06 | $12.41 M | |
| 03/30/2020 | Q4 2019 | -$0.27 | $1.06 M |
AC Immune SA Earnings: Frequently Asked Questions
-
When is AC Immune SA's earnings date?
AC Immune SA has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 13th, 2025 based off last year's report dates.
-
Did AC Immune SA beat their earnings estimates last quarter?
In the previous quarter, AC Immune SA (:ACIU) reported $0.06 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.22 by $0.28.
-
How can I listen to AC Immune SA's earnings conference call?
The conference call for AC Immune SA's latest earnings report can be listened to online.
-
How can I read AC Immune SA's conference call transcript?
The conference call transcript for AC Immune SA's latest earnings report can be read online.
-
How much revenue does AC Immune SA generate each year?
AC Immune SA (:ACIU) has a recorded annual revenue of $14.80 M.
-
How much profit does AC Immune SA generate each year?
AC Immune SA (:ACIU) has a recorded net income of $14.80 M. AC Immune SA has generated $-0.64 earnings per share over the last four quarters.
-
What is AC Immune SA's price-to-earnings ratio?
AC Immune SA (:ACIU) has a price-to-earnings ratio of -6.94 and price/earnings-to-growth ratio is -0.25.
